Physician profile
Casey H Johnson
NPI 1982710752
$2,429.33
in general payments reported to CMS, 2019-2025
20 companies · $247 in 2025
The $247 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $617 · 2020: $110 · 2021: $150 · 2022: $243 · 2023: $513 · 2024: $549 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,309.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $632.94 | 2019-2024 | Tecnis Iol |
| Alcon Vision LLC | $333.48 | 2019-2025 | Hydrus Microstent, Clareon, Tryptyr |
| Ocular Therapeutix, INC. | $330.35 | 2023-2024 | Dextenza |
| Abbvie INC. | $236.28 | 2022-2025 | |
| Oyster Point Pharma, INC. | $212.66 | 2022-2025 | Tyrvaya |
| Sight Sciences, INC. | $89.87 | 2019-2023 | Omni Surgical System |
| Sun Pharmaceutical Industries INC. | $89.00 | 2021-2025 | |
| Ani Pharmaceuticals, INC. | $75.77 | 2023-2024 | Purified Cortrophin Gel |
| New World Medical,INC. | $60.69 | 2022-2024 | Clearpath, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Tarsus Pharmaceuticals, INC. | $58.79 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $50.12 | 2024 | Oxervate |
| Halozyme INC | $47.10 | 2019-2021 | |
| Harrow Eye, LLC | $39.60 | 2023-2025 | Iheezo, Vevye |
| Aerie Pharmaceuticals, INC. | $35.77 | 2021 | |
| Allergan, INC. | $32.76 | 2020-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $28.39 | 2021 | |
| Rayner Intraocular Lenses Limited | $21.50 | 2024 | Rayone Spheric, Rayone Emv, Rayone Aspheric |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $20.14 | 2021 | |
| Novartis Pharmaceuticals Corporation | $18.64 | 2020 | |
| Eyevance Pharmaceuticals LLC | $15.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.